Get started
ORION PHARMA LTDOO

ORION PHARMA LTD

31.90BDTD
−0.70−2.15%
At close at Mar 3, 07:46 GMT
BDT
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

ORIONPHARM fundamentals

Key facts

Market capitalization‪7.63 B‬BDT
Dividend yield (indicated)3.07%
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−0.07BDT
Founded1965
Employees (FY)‪3.16 K‬
CEOZareen Karim
Websiteorionpharmabd.com
About

Orion Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the Pharmaceuticals and Power segments. The company was founded on June 21, 1965 and is headquartered in Dhaka, Bangladesh.

Ownership
‪‪234.00 M‬‬
Free Float shares
‪‪159.16 M‬‬ (68.02%)
Closely held shares
‪‪74.84 M‬‬ (31.98%)
Free Float shares
‪‪159.16 M‬‬ (68.02%)
Closely held shares
‪‪74.84 M‬‬ (31.98%)
Capital structure
Market cap
‪‪7.63 B‬‬
Debt
‪‪23.32 B‬‬
Minority interest
‪‪1.50 B‬‬
Cash & equivalents
‪‪334.76 M‬‬
Enterprise value
‪‪32.12 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪7.63 B‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
1.03x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
1.03x
Valuation ratios
‪0.00‬
‪0.40‬
‪0.80‬
‪1.20‬
‪1.60‬
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪15.00‬
‪30.00‬
‪45.00‬
‪60.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−18%‬
‪−12%‬
‪−6%‬
‪0%‬
‪6%‬
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−1.00 B‬‬
‪0.00‬
‪‪1.00 B‬‬
‪‪2.00 B‬‬
‪‪3.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−300.00 M‬‬
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−300.00 M‬‬
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Power
Pharmaceuticals
By country
Period: 2024
Bangladesh

Dividends

Dividend yield, history and sustainability

Dividend summary
−1,461.99%
Payout ratio (TTM)
Dividend yield TTM
3.07%
Last payment
1.00
Last ex-date
Dec 5, 2024
Dividend history
‪1.0%‬
‪1.4%‬
‪1.8%‬
‪2.2%‬
‪2.6%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.30‬
‪0.60‬
‪0.90‬
‪1.20‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−8.00 B‬‬
‪0.00‬
‪‪8.00 B‬‬
‪‪16.00 B‬‬
‪‪24.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪10.00 B‬‬
‪‪20.00 B‬‬
‪‪30.00 B‬‬
‪‪40.00 B‬‬
Assets
Liabilities